BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 11997417)

  • 1. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.
    Biffi M; Boriani G; Bartolotti M; Bacchi Reggiani L; Zannoli R; Branzi A
    Heart; 2002 May; 87(5):443-8. PubMed ID: 11997417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
    Singh SN; Tang XC; Reda D; Singh BN
    Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VErapamil plus antiarrhythmic drugs reduce atrial fibrillation recurrences after an electrical cardioversion (VEPARAF Study).
    De Simone A; De Pasquale M; De Matteis C; Canciello M; Manzo M; Sabino L; Alfano F; Di Mauro M; Campana A; De Fabrizio G; Vitale DF; Turco P; Stabile G
    Eur Heart J; 2003 Aug; 24(15):1425-9. PubMed ID: 12909071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation.
    Antonielli E; Pizzuti A; Pálinkás A; Tanga M; Gruber N; Michelassi C; Varga A; Bonzano A; Gandolfo N; Halmai L; Bassignana A; Imran MB; Delnevo F; Csanády M; Picano E
    J Am Coll Cardiol; 2002 May; 39(9):1443-9. PubMed ID: 11985905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical predictors and time course of arrhythmia recurrence in patients with early reinitiation of atrial fibrillation after successful internal cardioversion.
    Tse HF; Lau CP
    Pacing Clin Electrophysiol; 2003 Sep; 26(9):1809-14. PubMed ID: 12930494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
    Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low energy internal atrial cardioversion in atrial fibrillation lasting more than a year.
    Boriani G; Biffi M; Pergolini F; Zannoli R; Branzi A; Magnani B
    Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):243-6. PubMed ID: 9990639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation.
    Duytschaever M; Haerynck F; Tavernier R; Jordaens L
    Pacing Clin Electrophysiol; 1998 Jan; 21(1 Pt 2):284-7. PubMed ID: 9474689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T).
    Atwood JE; Myers JN; Tang XC; Reda DJ; Singh SN; Singh BN
    Am Heart J; 2007 Apr; 153(4):566-72. PubMed ID: 17383295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic predictors of sinus rhythm control by amiodarone and electrical cardioversion in patients undergoing percutaneous transluminal mitral valvuloplasty for rheumatic atrial fibrillation.
    Guo GB; Hang CL; Chang HW; Wu CJ; Fang CY; Chen CJ
    Circ J; 2007 Jul; 71(7):1115-9. PubMed ID: 17587720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation].
    Kosior D; Szulc M; Zawadzka M; Pierścińska M; Stawicki S; Rabczenko D; Torbicki A; Opolski G
    Pol Arch Med Wewn; 2002 Dec; 108(6):1151-60. PubMed ID: 12687927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of internal cardioversion for chronic atrial fibrillation in patients with and without left ventricular dysfunction.
    Boriani G; Biffi M; Camanini C; Corazza I; Martignani C; Valzania C; Gallina M; Grigioni F; Zannoli R; Rapezzi C; Branzi A
    Int J Cardiol; 2004 May; 95(1):43-7. PubMed ID: 15159037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of atrial electromechanical delay for atrial fibrillation recurrence.
    Ari H; Ari S; Akkaya M; Aydin C; Emlek N; Sarigül OY; Çetinkaya S; Bozat T; Şentürk M; Karaağaç K; Melek M; Yilmaz M
    Cardiol J; 2013; 20(6):639-47. PubMed ID: 24338542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?
    Tieleman RG; Van Gelder IC; Bosker HA; Kingma T; Wilde AA; Kirchhof CJ; Bennekers JH; Bracke FA; Veeger NJ; Haaksma J; Allessie MA; Crijns HJ
    Heart Rhythm; 2005 Mar; 2(3):223-30. PubMed ID: 15851308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.
    Galperín J; Elizari MV; Chiale PA; Molina RT; Ledesma R; Scapín AO; Blanco MV; Bonato R; Lago M;
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):179-86. PubMed ID: 14506542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early recurrence of atrial fibrillation after external cardioversion.
    Yu WC; Lin YK; Tai CT; Tsai CF; Hsieh MH; Chen CC; Hsu TL; Ding YA; Chang MS; Chen SA
    Pacing Clin Electrophysiol; 1999 Nov; 22(11):1614-9. PubMed ID: 10598964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study.
    Kosior DA; Opolski G; Wozakowska-Kaplon B; Rabczenko D;
    Cardiology; 2005; 104(1):35-44. PubMed ID: 15942183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome in patients with chronic atrial fibrillation after successful internal cardioversion.
    Tse HF; Lau CP; Ayers GM
    Am J Cardiol; 1999 Feb; 83(4):607-9, A8, A10. PubMed ID: 10073873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.